Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). (Q39707839)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
scientific article

    Statements

    Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). (English)
    Katsuhiko Uesaka
    Akira Fukutomi
    Yukiyasu Okamura
    Masaru Konishi
    Ippei Matsumoto
    Yuji Kaneoka
    Yasuhiro Shimizu
    Hirohiko Sakamoto
    Soichiro Morinaga
    Osamu Kainuma
    Koji Imai
    Naohiro Sata
    Shoichi Hishinuma
    Hitoshi Ojima
    Ryuzo Yamaguchi
    Satoshi Hirano
    Takeshi Sudo
    Yasuo Ohashi
    JASPAC 01 Study Group
    2 June 2016
    10041
    248-257

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit